CHeBA Proteomics is a collaborative group composed of staff and students from CHeBA, the Neuropsychiatric Institute (NPI) and the UNSW MW Analytical Centre Bioanalytical Mass Spectrometry Facility (BMSF).

About the Group: 

This interdisciplinary group was formed to apply state-of-the-art analytical techniques to the advancement of biomarker and pathophysiology research in the areas of normal ageing, mild cognitive im­pairment (MCI), Alzheimer’s Disease and other age-related neurodegenerative conditions. The group relies on a variety of mass spectrometry techniques, for proteomics, lipidomics and metabolomics analyses.

Group Aims

  1. Identify potential biomarkers in plasma samples of control, MCI and AD subjects, which will discriminate normal ageing from changes associated with pathology.
  2. Better understanding of the pathophysiological processes affecting the AD brain and in particular early or preclinical stages of AD such as MCI, using tissue, cell culture and animal models of ageing and disease.



Professor Perminder Sachdev

Emeritus Professor George Smythe

Dr Anne Poljak

Dr Nady Braidy

Dr Fei Song

Research Associates

Ms Tharusha Jayasena, PhD candidate

Biobank Officer: Technical Support

Ms Maboobeh Hosseini


Matthew Wong

Back to Top